Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Well that's Different ! 96% Strong Buy Tech Barchart !
View:
Post by Oden6570 on Mar 12, 2021 5:31am

Well that's Different ! 96% Strong Buy Tech Barchart !

Key Turning Points

3rd Resistance Point 0.370
2nd Resistance Point 0.330
1st Resistance Point 0.310
Last Price 0.290
1st Support Level 0.250
2nd Support Level 0.210
3rd Support Level 0.190
TLT.VN - Theralase Technologies Stock Price - Barchart.com
Comment by Rumpl3StiltSkin on Mar 12, 2021 9:43am
There is also an upward trendline from recent lows that we've been bouncing off of at ~ .235. Did it yesterday on huge volume.
Comment by Oden6570 on Mar 12, 2021 10:05am
IMHO someone Is accumulating, manipulating retail shareholders to sell seems so simple , they will not let it get over.30. The price drops down again on the ask rinse repeat over and over again.
Comment by Rumpl3StiltSkin on Mar 12, 2021 10:38am
I agee that is happening and newb retailers are the ones getting skewered. Looking at it purely technically, hard to do with a penny stock, TLT seems to be forming a bullish pendant. That Upward trendline at the bottom and .31/.32 area foming the upside. We should eventually breakout of this pendant to the upside.  I no longer consider TLT a pennny stock, not the way it is trading, not with ...more  
Comment by StevenBirch on Mar 12, 2021 11:46am
I don't know what bit of news it will be but the way it's trading it looks like a tightly wound spring ready to explode, reminds me of LLoyd Braun from Seinfeld
Comment by Bunge on Mar 12, 2021 12:03pm
Love it. Glad to see someone else be goofy for a while. How about some gifs. :P
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250